{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:03:19Z","timestamp":1753354999867,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key Discipline Construction Project of Pudong Health and Family Planning Commission of Shanghai","award":["PWZxk2017-21"],"award-info":[{"award-number":["PWZxk2017-21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12894-019-0513-1","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T14:05:43Z","timestamp":1567519543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-3024","authenticated-orcid":false,"given":"Qing-Tong","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"issue":"1","key":"513_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0090-4295(02)01784-3","volume":"60","author":"AJ Wein","year":"2002","unstructured":"Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology. 2002;60(1):7.","journal-title":"Urology"},{"issue":"2","key":"513_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Kerrebroeck PV, Victor A, Wein A. The standardization of terminology of lower urinary tract function: report from the standardisation subcommittee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167\u201378.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"513_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(SICI)1520-6777(1998)17:3<249::AID-NAU9>3.0.CO;2-D","volume":"17","author":"A Mattiasson","year":"1998","unstructured":"Mattiasson A, Djurhuus JC, Fonda D, Lose G, Nordling J, St\u00f6hrer M. Standardization of outcome studies in patients with lower urinary tract dysfunction: a report on general principles from the standardisation committee of the international continence society. Neurourol Urodyn. 1998;17(3):249\u201353.","journal-title":"Neurourol Urodyn"},{"key":"513_CR4","doi-asserted-by":"crossref","unstructured":"Bradley C, Psychol C. Patient-reported outcome measures: use in medical product development to support labeling claims FDA draft guidance or industry 2006. Health Qual Life Outcomes. 2006;4(1):79.","DOI":"10.1186\/1477-7525-4-78"},{"issue":"S1","key":"513_CR5","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1111\/j.1524-4733.2004.7s102.x","volume":"7","author":"LC Doward","year":"2004","unstructured":"Doward LC, Mckenna SP. Defining patient-reported outcomes. Value Health. 2004;7(S1):S4.","journal-title":"Value Health"},{"issue":"2","key":"513_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","volume":"68","author":"Y Homma","year":"2006","unstructured":"Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O. Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology. 2006;68(2):318\u201323.","journal-title":"Urology"},{"issue":"12","key":"513_CR7","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","volume":"104","author":"JR Duckett","year":"1997","unstructured":"Duckett JR, Hall S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997;104(12):1374\u20139.","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"513_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1023\/A:1023422208910","volume":"12","author":"PR Reese","year":"2003","unstructured":"Reese PR, Pleil AM, Okano GJ, Kelleher CJ. Multinational study of reliability and validity of the King\u2019s health questionnaire in patients with overactive bladder. Qual Life Res. 2003;12(4):427\u201342.","journal-title":"Qual Life Res"},{"issue":"12","key":"513_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/0895-4356(93)90142-N","volume":"46","author":"F Guillemin","year":"1993","unstructured":"Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417\u201332.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"513_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S1879-5226(10)60040-1","volume":"21","author":"CL Chou","year":"2010","unstructured":"Chou CL, Chuang YC, Wang CC, Kuo HC. Validity of the traditional Chinese version of the King\u2019s health questionnaire for Taiwanese patients with an overactive bladder. Urol Sci. 2010;21(4):180\u20134.","journal-title":"Urol Sci"},{"issue":"7","key":"513_CR11","first-page":"36","volume":"20","author":"S Quan","year":"2006","unstructured":"Quan S, Ning J, Guozeng W, Yulong Z, Jing Z, Li J, Yan G, Menqing X, Ma J. Epidemiological survey of BPH in men over 50 years old in Pu Dong new area. Chin J Androl. 2006;20(7):36\u20138.","journal-title":"Chin J Androl"},{"issue":"5","key":"513_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, Jr FF, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American urological association symptom index for benign prostatic hyperplasia. The measurement committee of the American Urological Association. J Urol. 1992;148(5):1549\u201357.","journal-title":"J Urol"},{"issue":"4","key":"513_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1464-410X.2003.04682.x","volume":"93","author":"P Moorthy","year":"2004","unstructured":"Moorthy P, Lapitan MCQuek PL, Lim PH. Prevalence of overactive bladder in Asian men: an epidemiological survey. BJU Int. 2004;93(4):528\u201331.","journal-title":"BJU Int"},{"issue":"3","key":"513_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00345-009-0460-7","volume":"28","author":"K H\u00f6fner","year":"2010","unstructured":"H\u00f6fner K. Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World J Urol. 2010;28(3):353.","journal-title":"World J Urol"},{"issue":"6","key":"513_CR15","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306.","journal-title":"Eur Urol"},{"issue":"3","key":"513_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0022-5347(01)65075-4","volume":"157","author":"TJ Peters","year":"1997","unstructured":"Peters TJ, Donovan JL, Kay HE, Abrams P, Rosette JJMCH, Porru D, Thuroff JW. The international continence society \u201cbenign prostatic hyperplasia\u201d study: the bothersomeness of urinary symptoms. J Urol. 1997;157(3):885\u20139.","journal-title":"J Urol"},{"issue":"1","key":"513_CR17","first-page":"194","volume":"49","author":"JY Lee","year":"2015","unstructured":"Lee JY, Kim HW, Lee SJ, Koh JS, Suh HJ, Chancellor MB. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int. 2015;49(1):194\u20135.","journal-title":"BJU Int"},{"issue":"3","key":"513_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/nau.1001","volume":"20","author":"T Knutson","year":"2001","unstructured":"Knutson T, Edlund C, Fall M, Dahlstrand C. BPH with coexisting overactive bladder dysfunction--an everyday urological dilemma. Neurourol Urodyn. 2001;20(3):237.","journal-title":"Neurourol Urodyn"},{"issue":"25","key":"513_CR19","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa030656","volume":"349","author":"JD Mcconnell","year":"2003","unstructured":"Mcconnell JD, Roehrborn CG, Bautista OM, Jr AG, Dixon CM, Kusek JW, Lepor H, Mcvary KT, Jr NL, Clarke HS. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387\u201398.","journal-title":"N Engl J Med"},{"issue":"7","key":"513_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.eursup.2003.09.002","volume":"2","author":"F Jim\u00e9nez-Cruz","year":"2003","unstructured":"Jim\u00e9nez-Cruz F. Identifying patients with lower urinary tract symptoms\/benign prostatic hyperplasia (LUTS\/BPH) at risk for progression. Eur Urol Suppl. 2003;2(7):6\u201312.","journal-title":"Eur Urol Suppl"},{"issue":"3","key":"513_CR21","first-page":"206","volume":"8","author":"FC Lowe","year":"2005","unstructured":"Lowe FC, Batista J, Berges R, Chartier-Kastler E, Conti G, Desgrandchamps F, Dreikorn K, O'Leary M, Perez M, Speakman M. Risk factors for disease progression in patients with lower urinary tract symptoms|[sol]|benign prostatic hyperplasia (LUTS|[sol]|BPH): a systematic analysis of expert opinion. Eur Urol Suppl. 2005;8(3):206.","journal-title":"Eur Urol Suppl"},{"issue":"1","key":"513_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0302-2838(02)00210-5","volume":"42","author":"CG Roehrborn","year":"2002","unstructured":"Roehrborn CG, Mcconnell JD, Saltzman B, Bergner D, Gray T, Narayan P, Cook TJ, Johnson-Levonas AO, Quezada WA, Waldstreicher J. Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. Eur Urol. 2002;42(1):1\u20136.","journal-title":"Eur Urol"},{"issue":"3","key":"513_CR23","first-page":"5","volume":"4","author":"C Roehrborn","year":"2005","unstructured":"Roehrborn C. 10 the impact of acute or chronic inflammation in baseline biopsy on the risk of progression in the MTOPS study. Eur Urol Suppl. 2005;4(3):5\u20135.","journal-title":"Eur Urol Suppl"},{"issue":"6","key":"513_CR24","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.urology.2013.01.042","volume":"81","author":"H Kwon","year":"2013","unstructured":"Kwon H, Kang HC, Lee JH. Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms. Urology. 2013;81(6):1325\u20139.","journal-title":"Urology"},{"issue":"6","key":"513_CR25","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.urology.2007.08.008","volume":"70","author":"K Zhang","year":"2007","unstructured":"Zhang K, Xu Z, Jing Z, Wang H, Zhang D, Shi B. Clinical significance of Intravesical prostatic protrusion in patients with benign prostatic enlargement. Urology. 2007;70(6):1096\u20139.","journal-title":"Urology"},{"issue":"9","key":"513_CR26","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/j.1464-410X.2005.05831.x","volume":"96","author":"MK Li","year":"2005","unstructured":"Li MK, Garcia LA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int. 2005;96(9):1339.","journal-title":"BJU Int"},{"issue":"12","key":"513_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1442-2042.2010.02668.x","volume":"17","author":"F Keong Tatt","year":"2010","unstructured":"Keong Tatt F. Decision making in the management of benign prostatic enlargement and the role of transabdominal ultrasound. Int J Urol. 2010;17(12):974\u20139.","journal-title":"Int J Urol"},{"issue":"10","key":"513_CR28","first-page":"554","volume":"9","author":"H Akihide","year":"2010","unstructured":"Akihide H, Shoji S, Ken F, Akira Y, Tatsuya A, Yoshihisa F. Comparison of parameters to determine the cause of urinary disturbance in men with prostate volume less than 20 milliliters. Int J Urol. 2010;9(10):554\u20139.","journal-title":"Int J Urol"},{"issue":"4","key":"513_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1046\/j.1464-410X.2003.04088.x","volume":"91","author":"SJ Chia","year":"2015","unstructured":"Chia SJ, Heng CTChan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2015;91(4):371\u20134.","journal-title":"BJU Int"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-019-0513-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12894-019-0513-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-019-0513-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:09:57Z","timestamp":1599001797000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-019-0513-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1186\/s12894-019-0513-1","relation":{},"ISSN":["1471-2490"],"issn-type":[{"type":"electronic","value":"1471-2490"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"5 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We verbally inform patients about the purpose of the study and the use of the data in a concise and understandable manner, and promise that all personal information collected will be kept confidential. The procedure has been approved by the ethics committee of Shanghai Pudong New Area Science and Technology Development (PKJ2012-18Y).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}